172 related articles for article (PubMed ID: 34144270)
21.
Wang Y; Kirkpatrick J; Zur Lage S; Korn SM; Neißner K; Schwalbe H; Schlundt A; Carlomagno T
Biomol NMR Assign; 2021 Oct; 15(2):287-295. PubMed ID: 33770349
[TBL] [Abstract][Full Text] [Related]
22. Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2.
Wang Y; Kirkpatrick J; Lage SZ; Carlomagno T
Structure; 2023 Feb; 31(2):128-137.e5. PubMed ID: 36610391
[TBL] [Abstract][Full Text] [Related]
23. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
Benedetti F; Snyder GA; Giovanetti M; Angeletti S; Gallo RC; Ciccozzi M; Zella D
J Transl Med; 2020 Aug; 18(1):329. PubMed ID: 32867854
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).
de Lima Menezes G; da Silva RA
J Biomol Struct Dyn; 2021 Sep; 39(15):5657-5667. PubMed ID: 32657643
[TBL] [Abstract][Full Text] [Related]
26. Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin.
Lokugamage KG; Narayanan K; Nakagawa K; Terasaki K; Ramirez SI; Tseng CT; Makino S
J Virol; 2015 Nov; 89(21):10970-81. PubMed ID: 26311885
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression.
Nakagawa K; Makino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33540583
[TBL] [Abstract][Full Text] [Related]
28. In vitro reconstitution of SARS-CoV-2 Nsp1-induced mRNA cleavage reveals the key roles of the N-terminal domain of Nsp1 and the RRM domain of eIF3g.
Abaeva IS; Arhab Y; Miścicka A; Hellen CUT; Pestova TV
Genes Dev; 2023 Sep; 37(17-18):844-860. PubMed ID: 37821106
[TBL] [Abstract][Full Text] [Related]
29. Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation.
Kumar P; Schexnaydre E; Rafie K; Kurata T; Terenin I; Hauryliuk V; Carlson LA
FEBS Lett; 2022 May; 596(9):1203-1213. PubMed ID: 35434785
[TBL] [Abstract][Full Text] [Related]
30. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
[TBL] [Abstract][Full Text] [Related]
31. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp).
da Silva FMA; da Silva KPA; de Oliveira LPM; Costa EV; Koolen HH; Pinheiro MLB; de Souza AQL; de Souza ADL
Mem Inst Oswaldo Cruz; 2020; 115():e200207. PubMed ID: 33027419
[TBL] [Abstract][Full Text] [Related]
32. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing.
Chan WM; Ip JD; Chu AW; Yip CC; Lo LS; Chan KH; Ng AC; Poon RW; To WK; Tsang OT; Leung WS; Kwan MY; Chua GT; Chung TW; Hung IF; Kok KH; Cheng VC; Chan JF; Yuen KY; To KK
J Med Virol; 2020 Nov; 92(11):2725-2734. PubMed ID: 32501535
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase α-primase.
Kilkenny ML; Veale CE; Guppy A; Hardwick SW; Chirgadze DY; Rzechorzek NJ; Maman JD; Pellegrini L
Protein Sci; 2022 Feb; 31(2):333-344. PubMed ID: 34719824
[TBL] [Abstract][Full Text] [Related]
34. Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an
Ogunyemi OM; Gyebi GA; Elfiky AA; Afolabi SO; Ogunro OB; Adegunloye AP; Ibrahim IM
Antivir Chem Chemother; 2020; 28():2040206620984076. PubMed ID: 33372806
[TBL] [Abstract][Full Text] [Related]
35. Extended ensemble simulations of a SARS-CoV-2 nsp1-5'-UTR complex.
Sakuraba S; Xie Q; Kasahara K; Iwakiri J; Kono H
PLoS Comput Biol; 2022 Jan; 18(1):e1009804. PubMed ID: 35045069
[TBL] [Abstract][Full Text] [Related]
36. In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
El Hassab MA; Ibrahim TM; Al-Rashood ST; Alharbi A; Eskandrani RO; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):727-736. PubMed ID: 33685335
[TBL] [Abstract][Full Text] [Related]
37. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
38. Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants.
Parida PK; Paul D; Chakravorty D
Phytomed Plus; 2021 Feb; 1(1):100002. PubMed ID: 35403083
[TBL] [Abstract][Full Text] [Related]
39. Structure of alphacoronavirus transmissible gastroenteritis virus nsp1 has implications for coronavirus nsp1 function and evolution.
Jansson AM
J Virol; 2013 Mar; 87(5):2949-55. PubMed ID: 23269811
[TBL] [Abstract][Full Text] [Related]
40. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
Singh R; Bhardwaj VK; Purohit R
Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
